Latest Period
Q1 2026
Security Snapshot
Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT) Institutional Ownership
CUSIP: 097702203
13F Institutional Holders and Ownership History from Q2 2025 to Q1 2026
Institutions Reporting
24
Shares (Excl. Options)
613,252
Price
$4.04
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, $0.00001 par value
- Symbol
- BOLT on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 613,252
- Total 13F value
- $2,488,203
- Portfolio coverage rank
- 0%
- Share change
- +10,714
- Value change
- +$42,876
- Number of holders
- 24
- Shares outstanding
- 1,901,870
- SEC-reported price per share
- $4.04
- Insider filing price
- $4.04
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- BOLT - Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value is tracked under CUSIP 097702203.
- 24 institutions reported positions in Q1 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 21 to 24 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $3,295,047 to $2,488,203.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 24 institutions filings for Q1 2026.
Security key
097702203
Latest holder period
Q1 2026
13F holders
24
13D/G owners
2
CIK / CUSIP context first
Open Q1 2026 holders
BOLT full holder history
Bolt Biotherapeutics, Inc. SEC filings
Bolt Biotherapeutics, Inc. company facts
Bolt Biotherapeutics, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 097702203:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
BOLT
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Pivotal bioVenture Partners Fund I, L.P. | 4.6% | -30% | $478,373 | -$222,181 | 87,486 | -32% | Nan Fung Group Holdings Limited | 24 Feb 2026 |
| TANG CAPITAL MANAGEMENT LLC | 3.5% | -58% | $355,790 | -$531,990 | 66,879 | -60% | TANG CAPITAL MANAGEMENT, LLC | 30 Sep 2025 |
As of 31 Mar 2026, 24 institutional investors reported holding 613,252 shares of Bolt Biotherapeutics, Inc. - Common Stock, $0.00001 par value (BOLT). This represents 32% of the company’s total 1,901,870 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
32%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| Sofinnova Investments, Inc. | 7.2% | 137,721 | 0% | 0.03% | $556,393 |
| RENAISSANCE TECHNOLOGIES LLC | 4.1% | 77,225 | +40% | 0% | $311,989 |
| Vivo Capital, LLC | 3.8% | 72,414 | 0% | 0.02% | $292,553 |
| Pivotal bioVenture Partners Investment Advisor LLC | 2.2% | 42,581 | -55% | 0.06% | $172,027 |
| T3 Companies, LLC | 2% | 38,000 | 0% | 0.21% | $153,520 |
| Board of Trustees of The Leland Stanford Junior University | 1.9% | 35,977 | 0% | 0.02% | $145,347 |
| Pfizer Inc | 1.6% | 31,305 | 0% | 0.06% | $137,116 |
| Lynx1 Capital Management LP | 1.6% | 30,800 | 0.02% | $124,432 | |
| Nan Fung Group Holdings Ltd | 1.5% | 29,250 | -50% | 0.1% | $118,170 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.5% | 28,791 | +53% | 0% | $116,329 |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 1.4% | 27,500 | +34% | 0.1% | $111,100 |
| Shay Capital LLC | 0.78% | 14,905 | -2.4% | 0.01% | $60,216 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 0.61% | 11,657 | 0% | $47,094 | |
| CITADEL ADVISORS LLC | 0.53% | 10,109 | 0% | $40,840 | |
| BlackRock, Inc. | 0.51% | 9,711 | 0% | 0% | $39,233 |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.37% | 7,060 | 0% | 0% | $28,522 |
| MORGAN STANLEY | 0.17% | 3,189 | +2% | 0% | $12,883 |
| VANGUARD FIDUCIARY TRUST CO | 0.16% | 3,095 | 0% | 0% | $12,504 |
| Tower Research Capital LLC (TRC) | 0.06% | 1,093 | +51% | 0% | $4,416 |
| UBS Group AG | 0.04% | 787 | +53% | 0% | $3,179 |
| JPMORGAN CHASE & CO | 0% | 42 | 0% | 0% | $179 |
| Vanguard Global Advisers, LLC | 0% | 24 | 0% | 0% | $97 |
| SBI Securities Co., Ltd. | 0% | 10 | 0% | 0% | $40 |
| BARCLAYS PLC | 0% | 6 | 0% | 0% | $24 |
| BANK OF AMERICA CORP /DE/ | 0% | 0 | -100% | $0 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
4
Latest
Q1 2026
Rows shown
1-4 of 4